We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




测量组织切片的RNA表达

By LabMedica International staff writers
Posted on 24 Oct 2012
科学家成功地直接测量了组织切片中的RNA表达,灵敏度达到单拷贝级别。

QuantiGene ViewRNA ISH组织测定被用于RNA测量。市面上已经有了一千多种标准探针,只需几天就能为新基因靶体生成一只定制的探针。

Affymetrix公司(Santa Clara, CA, USA; www.affymetrix.com)的QuantiGene ViewRNA原位杂交(ISH)组织测定将在徕卡(Wetzlar, Germany; www.leica.com)的Bond RX染色平台上实现自动化。两家公司的合作将极大缩短单拷贝RNA原位杂交(ISH)分析的测定时间。它将为科学家提供强大的药物发明自动化日常解决方案、转化研究,并开发新型结合诊断检验,以实现个性化医药。

徕卡Bond RX系统稳定而快速,实现了染色过程的自动化。这意味着研究人员能采用标准化染色预案,快速设置任何探针,从而在当天完成测定。

Affymetrix公司表达事业部——Panomics副总裁兼总经理George Bers表示:“与徕卡的合作使我们兴奋不已,因为它使单拷贝RNA分析的真正潜力得以释放,我们相信它将加速重要新药的发明以及新型结合检验的确证。”

Affymetrix公司的QuantiGene ViewRNA ISH组织测定将在2012年第三季度面市。经过优化的QuantiGene ViewRNA染色预案将被预加载到徕卡BOND RX上,Affymetrix公司将提供一套完整的染色试剂盒,包括探针和所有的检测组件。

Related Links:

Affymetrix >> www.affymetrix.com

Leica >> www.leica.com

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Online QC Software
Acusera 24•7
New
All-in-One Molecular System
AIO M160
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.